中文 | English
Return
Total: 782 , 1/79
Show Home Prev Next End page: GO
Author:(Shan YUN)

1.Improvement effects and mechanism of astragaloside Ⅳ on neuroinflammation

Mimi WANG ; Yonggang FENG ; Yun HAN ; Kaixin SHAN ; Fuyu LIU ; Mingsan MIAO ; Xiaoyan FANG

China Pharmacy 2026;37(1):30-35

2.Inhibitory effect of calycosin-7-glucoside on lipopolysaccharide-induced neuroinflammation via the TLR4/MyD88/NF-κB signaling pathway

Yun HAN ; Yonggang FENG ; Mimi WANG ; Kaixin SHAN ; Mingsan MIAO ; Xiaoyan FANG

Chinese Journal of Comparative Medicine 2025;35(8):48-57

3.Research progress on glucose metabolism reprogramming of tumor-associated macrophages in gastric cancer

Yun-tian DENG ; Yuan GU ; Yi-hong SUN ; Hong-shan WANG

Fudan University Journal of Medical Sciences 2025;52(5):717-723

4.The synergistic effect and mechanism verification of effective components of Biejia-Ezhu against triple-negative breast cancer based on network pharmacology and component compatibility theory

Dou-dou FENG ; Xiao-shan LUO ; Yan-yun MENG ; Jing-zhe ZHAO ; Jiu-long ZHU ; Ya-zhen HUANG ; Qing XIE ; Xiang-Li LING ; Su XIE

Chinese Pharmacological Bulletin 2025;41(5):950-959

5.Construction of a predictive model for estimating the insertion length of peripherally inserted central catheter in very low birth weight infants

Jiaxin LI ; Yubing DONG ; Aifen CAO ; Shan JIANG ; Yingsui HUANG ; Yun LONG ; Xiaoyun XIONG

Chinese Journal of Practical Nursing 2025;41(34):2709-2713

6.Chemical constituents from ethyl acetate fraction of Balanophora harlandii and their tyrosinase inhibitory activity

Zhang-xian CHEN ; Hai-ming WANG ; Yun-tao ZHANG ; Mao-xin DENG ; Kui-lin ZHU ; Jin-lian ZOU ; Jian WANG ; Shan-shan WEI ; Hong-ping HE ; Fa-wu DONG

Chinese Traditional Patent Medicine 2025;47(10):3290-3297

7.Research of miR-508-3p involvement in ovarian cancer progression by regulating ZEB1

Yu-hong XU ; Shuai-ying ZHU ; Jiang-jing SHAN ; Wei-ping ZHENG ; Hui-ya ZHANG ; Yun-gen WANG

The Chinese Journal of Clinical Pharmacology 2025;41(2):193-197

8.Exploration of the Prevention and Treatment of Peritoneal Dialysis-Related Peritoneal Fibrosis with Invigorating Qi,Detoxif-ying,and Resolving Stasis Method Based on Collateral Disease Theory

Yongqing YOU ; Manshu YU ; Yun SHAN ; Rong XU ; Jin YAN ; Jinyi SUN ; Meixiao SHENG

Journal of Nanjing University of Traditional Chinese Medicine 2025;41(8):1021-1026

9.The synergistic effect and mechanism verification of effective components of Biejia-Ezhu against triple-negative breast cancer based on network pharmacology and component compatibility theory

Dou-dou FENG ; Xiao-shan LUO ; Yan-yun MENG ; Jing-zhe ZHAO ; Jiu-long ZHU ; Ya-zhen HUANG ; Qing XIE ; Xiang-Li LING ; Su XIE

Chinese Pharmacological Bulletin 2025;41(5):950-959

10.Research of miR-508-3p involvement in ovarian cancer progression by regulating ZEB1

Yu-hong XU ; Shuai-ying ZHU ; Jiang-jing SHAN ; Wei-ping ZHENG ; Hui-ya ZHANG ; Yun-gen WANG

The Chinese Journal of Clinical Pharmacology 2025;41(2):193-197

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 782 , 1/79 Show Home Prev Next End page: GO